Report: Wind Energy in the US is now Cheaper Than Ever
By Jocelyn Aspa
The US Department of Energy’s report shows that wind energy prices are at significant lows compared to 2009.
Your trusted source for investing success
Your trusted source for investing success
By Jocelyn Aspa
The US Department of Energy’s report shows that wind energy prices are at significant lows compared to 2009.
By Jocelyn Aspa
Ascent Solar Technologies (OTCQB:ASTI) has added Dr. Miguel Contreras to its team effective July 10, 2017 as the director of process engineering.
As quoted in the press release:
Dr. Contreras, formerly a Senior Scientist at the National Renewable Energy Laboratory (NREL), was a key member of the team that achieved the world-record
By Shelly Kumar
Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE: ATT) (OTCQB: ATTBF) is pleased to announce the addition of Siobhan McCarthy as Sales & Marketing Manager for the Company’s subsidiary Northern Vine Canada Inc. (“Northern Vine”).
Ms. McCarthy brings more than 20 years of direct sales and marketing experience to the Company
By Pia Rivera
Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company is pleased to announce the appointment of Dr. Amy Ripka and Dr. Rick Panicucci to its board of scientific advisors.
NeuroVive Pharmaceutical, the mitochondrial medicine company, today announced that the company has recruited Michele Tavecchio, PhD, as senior scientist.
Corvus Pharmaceuticals, a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology therapies, today announced preclinical data as well as preliminary biomarker data from its ongoing Phase 1/1b study of CPI-444 as a single agent and in combination with Genentech’s TECENTRIQ™ (atezolizumab).
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology therapies, today announced that it will present preclinical data, and preliminary biomarker data from its ongoing Phase 1/1b study of CPI-444 as a single agent, and in combination with Genentech’s TECENTRIQ™ (atezolizumab), in
PITTSBURGH, PA–(Marketwired – Aug 8, 2016) – Recognizing the massive growth potential of MicroElectroMechanical systems (MEMS) and sensors in Internet of Things (IoT) applications, MEMS & Sensors Industry Group (MSIG) will hold its third annual MEMS & Sensors Industry Group® Conference Asia in Shanghai, China on September 13-14, 2016.
Poster Discussion Sessions highlight the most clinically applicable and novel posters
PRINCETON, N.J., April 25, 2016 (GLOBE NEWSWIRE) — Advaxis, Inc. (NASDAQ:ADXS), a clinical stage biotechnology company developing cancer immunotherapies, today announced that the Company’s immunotherapy agent will be featured in a poster presentation and discussion at the American Society of Clinical
Study Using Patient-Derived Cells Within Human Extracellular Matrix (ECM) to Replicate Heterogeneous Tumor Microenvironments Aims to Improve Breast and Ovarian Cancer Treatment by Decreasing Anti-cancer Drug Failure Rates on a Large-Scale
SCOTTSDALE, AZ–(Marketwired – March 30, 2016) – Lattice Biologics Ltd. (TSX VENTURE: LBL)(OTCBB: BLVKF) (“Lattice Biologics” or the “Company”) is pleased
The Investing News Network had the chance to speak with Robin Eves, president and CEO of Clean Coal Technologies, about the company’s technology and what cleaner coal means for the future of power generation.
M Pharmaceutical Inc. (CSE:MQ) announced it has engaged Dr. Roy M. Kulick, MD, as clinical development adviser. Dr. Kulick will prepare clinical trial plans for the company’s lead product, Trimeo, which are capsules for the treatment of obesity.
Canada Carbon (TSXV:CCB) says it has begun a qualification process for obtaining off-take agreements with specialty graphite processors. The company has also started cooperative academic research and development programs with two academic institutions in Quebec.
A team of 70 scientists from the United States, China, Australia and Japan have successfully sequenced the genome of the “sacred lotus” they believe could hold secrets about aging, Latinos Post reports.
By Vivien Diniz
CNBC reported that a nuclear power partnership between General Electric Co. and Hitachi was granted federal approval on Tuesday to construct the first uranium enrichment plant for commercial use.
